Shares of Vanda Pharmaceuticals (VNDA) rise 2.36% premarket and look set to add to what has become quite a rally. The stock is up 109% over the past month, gathering momentum from analyst praise (I, II), positive commentary from the Tech Council of Maryland, and an NDA application for Tasimelteon. The company will present at the Jefferies Global Healthcare Conference tomorrow at 2:30.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs